What does a business do when the unimaginable happens? – The changing world order according to COVID-19

Joanna Schulman

CEO,  AIDIA Collective
Joanna is Founder and CEO of AIDIA Collective (Artificial Intelligence + Digital Innovation + Advisory) a digital health technology development and commercialization company. AIDIA works with solutions that address the underlying behavioral components of disease and promote health resilience. Joanna identifies new commercialization channels helping companies integrate their digital technologies into the continuum of care via payer, provider and partner networks. Prior to AIDIA, Joanna was Managing Partner of Thallo Bioscience Advisors a transactional and strategic advisory firm serving clients globally in the Life Sciences sector. There she worked with over 100+ companies on developing and executing partnering, licensing, M&A and capital investment deals. Joanna is deeply committed to helping promising technologies and companies become our healthcare future now.  She is an advisor and mentor to many start-ups and has consulted with international biopharma companies, government institutions and investment groups. 

Laura Raynak – Principal/Founder  Raynak Executive Search

Laura Raynak exemplifies the best characteristics of the executives she looks for: a head for science and a heart for people, the vision to recognize the big picture, and the focus to track the details.  She is one of those rare people who has the instinct to know when something will work out, and when it won’t.

Raynak Executive Search has been serving the San Francisco Bay Area to Los Angeles for over 18 years as an executive talent scout for companies in the life science industry.

Laura earned her BA degree in Biochemistry and Molecular Biology from the University of California, Santa Cruz, and holds a Certificate in Human Resources Management from UC Extension. Laura is a past board member of the NCHRA, an invited expert speaker, and is involved in several community organizations in the executive search and life sciences industry.

Ravi Kiron – Head, BioPharma External Innovation, EMD Serono, Inc.

Dr. Kiron is an experienced pharma/biotech executive with decades of experience from early drug discovery through late-stage clinical development, intellectual property, regulatory strategy and product commercialization. He currently serves as Head of BioPharma External Innovation at EMD Serono, the biopharmaceutical division of Merck KGaA. Dr. Kiron has consulted for dozens of life sciences companies, founded and led multiple new ventures, was an EIR at SRI Ventures, and serves currently on many company and non-profit boards. Dr. Kiron has also held operational & executive roles at Pfizer and J&J/Alza in cardiovascular and oncology R&D and strategic business development. He has a wide breadth of hands-on experience negotiating and executing partnerships, mergers and acquisitions, and has extensive global networks. Previously, he was a faculty member at Cornell University Medical College and at University of Rhode Island. Dr. Kiron earned BS and MS degrees from the University of Mumbai, a PhD from the Indian Institute of Science, and an MBA from Rensselaer Polytechnic Institute.

Event Information

Event Topic:
What does a business do when the unimaginable happens? – The changing world order according to COVID-19

Event Description:
Covid has changed our lives across the board. Home is now the office, work is blended with family life, Zoom has entered our language and dominates our days. And while these are some of the obvious external adaptations to life during Covid, business operations during the pandemic have also undergone sweeping changes. The 3 panelists represent a wide cross-section of the life sciences industry, from medtech to biopharma, large company to startups, hiring to finance. Their conversation will explore how our sector businesses have navigated and adjusted to the cascade of Covid effects including issues of safety, clinical trials, product pivots, supply chain, hiring and finance. The panelists will also discuss which changes may be here to stay and how that will affect the business of life sciences moving forward. The panel will be an interactive discussion and encourages attendees to submit questions throughout.

Date/Time:
Date(s) - 02/02/21
8:30 am - 10:30 am

Event Location:
Zoom talk: https://us02web.zoom.us/j/88274227563:

Speaker Information

Event Speaker:

Event Speaker Title:

Event Speaker Company:

Event Speaker Bio:

Event Details

Cost:
$0

Add To Calendar